Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 生物化學暨分子生物學科研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/32217
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor周綠蘋(Lu-Ping Chow)
dc.contributor.authorJr-Shiuan Yangen
dc.contributor.author楊致瑄zh_TW
dc.date.accessioned2021-06-13T03:37:15Z-
dc.date.available2009-08-04
dc.date.copyright2006-08-04
dc.date.issued2006
dc.date.submitted2006-07-26
dc.identifier.citation1. Kelley, J.R. and Duggan, J.M. (2003) Gastric cancer epidemiology and risk factors. J Clin Epidemiol, 56, 1-9.
2. Crew, K.D. and Neugut, A.I. (2006) Epidemiology of gastric cancer. World J Gastroenterol, 12, 354-362.
3. Correa, P. (1996) Helicobacter pylori and gastric cancer: state of the art. Cancer Epidemiol Biomarkers Prev, 5, 477-481.
4. Powell, J. and McConkey, C.C. (1992) The rising trend in oesophageal adenocarcinoma and gastric cardia. Eur J Cancer Prev, 1, 265-269.
5. Armstrong, R.W. and Borman, B. (1996) Trends in incidence rates of adenocarcinoma of the oesophagus and gastric cardia in New Zealand, 1978-1992. Int J Epidemiol, 25, 941-947.
6. Hansen, S., Wiig, J.N., Giercksky, K.E. and Tretli, S. (1997) Esophageal and gastric carcinoma in Norway 1958-1992: incidence time trend variability according to morphological subtypes and organ subsites. Int J Cancer, 71, 340-344.
7. Harrison, S.L., Goldacre, M.J. and Seagroatt, V. (1992) Trends in registered incidence of oesophageal and stomach cancer in the Oxford region, 1974-88. Eur J Cancer Prev, 1, 271-274.
8. Levi, F., La Vecchia, C. and Te, V.C. (1990) Descriptive epidemiology of adenocarcinomas of the cardia and distal stomach in the Swiss Canton of Vaud. Tumori, 76, 167-171.
9. Moller, H. (1992) Incidence of cancer of oesophagus, cardia and stomach in Denmark. Eur J Cancer Prev, 1, 159-164.
10. Pera, M., Cameron, A.J., Trastek, V.F., Carpenter, H.A. and Zinsmeister, A.R. (1993) Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology, 104, 510-513.
11. Thomas, R.J., Lade, S., Giles, G.G. and Thursfield, V. (1996) Incidence trends in oesophageal and proximal gastric carcinoma in Victoria. Aust N Z J Surg, 66, 271-275.
12. Lagergren, J., Bergstrom, R. and Nyren, O. (1999) Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med, 130, 883-890.
13. Hohenberger, P. and Gretschel, S. (2003) Gastric cancer. Lancet, 362, 305-315.
14. Terry, P., Lagergren, J., Ye, W., Wolk, A. and Nyren, O. (2001) Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology, 120, 387-391.
15. (1997) Cancer incidence in five continents. Volume VII. IARC Sci Publ, i-xxxiv, 1-1240.
16. McMichael, A.J., McCall, M.G., Hartshorne, J.M. and Woodings, T.L. (1980) Patterns of gastro-intestinal cancer in European migrants to Australia: the role of dietary change. Int J Cancer, 25, 431-437.
17. Howson, C.P., Hiyama, T. and Wynder, E.L. (1986) The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev, 8, 1-27.
18. Marshall, B.J. and Warren, J.R. (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet, 1, 1311-1315.
19. Parsonnet, J. (1995) The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther, 9 Suppl 2, 45-51.
20. Hu, P.J., Mitchell, H.M., Li, Y.Y., Zhou, M.H. and Hazell, S.L. (1994) Association of Helicobacter pylori with gastric cancer and observations on the detection of this bacterium in gastric cancer cases. Am J Gastroenterol, 89, 1806-1810.
21. Sipponen, P., Kosunen, T.U., Valle, J., Riihela, M. and Seppala, K. (1992) Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol, 45, 319-323.
22. Kokkola, A., Valle, J., Haapiainen, R., Sipponen, P., Kivilaakso, E. and Puolakkainen, P. (1996) Helicobacter pylori infection in young patients with gastric carcinoma. Scand J Gastroenterol, 31, 643-647.
23. Hansson, L.E., Engstrand, L., Nyren, O., Evans, D.J., Jr., Lindgren, A., Bergstrom, R., Andersson, B., Athlin, L., Bendtsen, O. and Tracz, P. (1993) Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology, 105, 1098-1103.
24. Miehlke, S., Hackelsberger, A., Meining, A., von Arnim, U., Muller, P., Ochsenkuhn, T., Lehn, N., Malfertheiner, P., Stolte, M. and Bayerdorffer, E. (1997) Histological diagnosis of Helicobacter pylori gastritis is predictive of a high risk of gastric carcinoma. Int J Cancer, 73, 837-839.
25. Kikuchi, S., Wada, O., Nakajima, T., Nishi, T., Kobayashi, O., Konishi, T. and Inaba, Y. (1995) Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults. Cancer, 75, 2789-2793.
26. Barreto-Zuniga, R., Maruyama, M., Kato, Y., Aizu, K., Ohta, H., Takekoshi, T. and Bernal, S.F. (1997) Significance of Helicobacter pylori infection as a risk factor in gastric cancer: serological and histological studies. J Gastroenterol, 32, 289-294.
27. Buckley, M.J., O'Shea, J., Grace, A., English, L., Keane, C., Hourihan, D. and O'Morain, C.A. (1998) A community-based study of the epidemiology of Helicobacter pylori infection and associated asymptomatic gastroduodenal pathology. Eur J Gastroenterol Hepatol, 10, 375-379.
28. Kurosawa, M., Kikuchi, S., Inaba, Y., Ishibashi, T. and Kobayashi, F. (2000) Helicobacter pylori infection among Japanese children. J Gastroenterol Hepatol, 15, 1382-1385.
29. Olmos, J.A., Rios, H. and Higa, R. (2000) Prevalence of Helicobacter pylori infection in Argentina: results of a nationwide epidemiologic study. Argentinean Hp Epidemiologic Study Group. J Clin Gastroenterol, 31, 33-37.
30. Webb, P.M., Knight, T., Greaves, S., Wilson, A., Newell, D.G., Elder, J. and Forman, D. (1994) Relation between infection with Helicobacter pylori and living conditions in childhood: evidence for person to person transmission in early life. Bmj, 308, 750-753.
31. Goodman, K.J. and Correa, P. (2000) Transmission of Helicobacter pylori among siblings. Lancet, 355, 358-362.
32. (1994) IARC working group on the evaluation of carcinogenic risks to humans: some industrial chemicals. Lyon, 15-22 February 1994. IARC Monogr Eval Carcinog Risks Hum, 60, 1-560.
33. Peek, R.M., Jr. (2001) IV. Helicobacter pylori strain-specific activation of signal transduction cascades related to gastric inflammation. Am J Physiol Gastrointest Liver Physiol, 280, G525-530.
34. Stalnikowicz, R. and Benbassat, J. (1990) Risk of gastric cancer after gastric surgery for benign disorders. Arch Intern Med, 150, 2022-2026.
35. Kono, S. and Hirohata, T. (1996) Nutrition and stomach cancer. Cancer Causes Control, 7, 41-55.
36. Joossens, J.V., Hill, M.J., Elliott, P., Stamler, R., Lesaffre, E., Dyer, A., Nichols, R. and Kesteloot, H. (1996) Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Int J Epidemiol, 25, 494-504.
37. Buiatti, E., Palli, D., Decarli, A., Amadori, D., Avellini, C., Bianchi, S., Bonaguri, C., Cipriani, F., Cocco, P., Giacosa, A. et al. (1990) A case-control study of gastric cancer and diet in Italy: II. Association with nutrients. Int J Cancer, 45, 896-901.
38. Hsing, A.W., Hansson, L.E., McLaughlin, J.K., Nyren, O., Blot, W.J., Ekbom, A. and Fraumeni, J.F., Jr. (1993) Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer, 71, 745-750.
39. Aird, I., Bentall, H.H. and Roberts, J.A. (1953) A relationship between cancer of stomach and the ABO blood groups. Br Med J, 1, 799-801.
40. Palli, D., Galli, M., Caporaso, N.E., Cipriani, F., Decarli, A., Saieva, C., Fraumeni, J.F., Jr. and Buiatti, E. (1994) Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomarkers Prev, 3, 15-18.
41. La Vecchia, C., Negri, E., Franceschi, S. and Gentile, A. (1992) Family history and the risk of stomach and colorectal cancer. Cancer, 70, 50-55.
42. Lissowska, J., Groves, F.D., Sobin, L.H., Fraumeni, J.F., Jr., Nasierowska-Guttmejer, A., Radziszewski, J., Regula, J., Hsing, A.W., Zatonski, W., Blot, W.J. et al. (1999) Family history and risk of stomach cancer in Warsaw, Poland. Eur J Cancer Prev, 8, 223-227.
43. Everhart, J.E. (2000) Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am, 29, 559-578.
44. Ernst, P.B. and Gold, B.D. (2000) The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol, 54, 615-640.
45. Miyaji, H., Azuma, T., Ito, S., Abe, Y., Gejyo, F., Hashimoto, N., Sugimoto, H., Suto, H., Ito, Y., Yamazaki, Y. et al. (2000) Helicobacter pylori infection occurs via close contact with infected individuals in early childhood. J Gastroenterol Hepatol, 15, 257-262.
46. Lauren, P. (1965) The Two Histological Main Types of Gastric Carcinoma: Diffuse and So-Called Intestinal-Type Carcinoma. an Attempt at a Histo-Clinical Classification. Acta Pathol Microbiol Scand, 64, 31-49.
47. Frenck, R.W., Jr. and Clemens, J. (2003) Helicobacter in the developing world. Microbes Infect, 5, 705-713.
48. Klein, P.D., Gilman, R.H., Leon-Barua, R., Diaz, F., Smith, E.O. and Graham, D.Y. (1994) The epidemiology of Helicobacter pylori in Peruvian children between 6 and 30 months of age. Am J Gastroenterol, 89, 2196-2200.
49. Konturek, P.C., Konturek, S.J., Pierzchalski, P., Bielanski, W., Duda, A., Marlicz, K., Starzynska, T. and Hahn, E.G. (2001) Cancerogenesis in Helicobacter pylori infected stomach--role of growth factors, apoptosis and cyclooxygenases. Med Sci Monit, 7, 1092-1107.
50. Morita, D., Ichikura, T. and Mochizuki, H. (2001) [The expression of PPAR gamma in gastric cancer]. Nippon Rinsho, 59 Suppl 4, 595-597.
51. Kitadai, Y., Sasaki, A., Ito, M., Tanaka, S., Oue, N., Yasui, W., Aihara, M., Imagawa, K., Haruma, K. and Chayama, K. (2003) Helicobacter pylori infection influences expression of genes related to angiogenesis and invasion in human gastric carcinoma cells. Biochem Biophys Res Commun, 311, 809-814.
52. Sepulveda, A.R., Tao, H., Carloni, E., Sepulveda, J., Graham, D.Y. and Peterson, L.E. (2002) Screening of gene expression profiles in gastric epithelial cells induced by Helicobacter pylori using microarray analysis. Aliment Pharmacol Ther, 16 Suppl 2, 145-157.
53. Yoshida, N., Ishikawa, T., Ichiishi, E., Yoshida, Y., Hanashiro, K., Kuchide, M., Uchiyama, K., Kokura, S., Ichikawa, H., Naito, Y. et al. (2003) The effect of rebamipide on Helicobacter pylori extract-mediated changes of gene expression in gastric epithelial cells. Aliment Pharmacol Ther, 18 Suppl 1, 63-75.
54. Noach, L.A., Bosma, N.B., Jansen, J., Hoek, F.J., van Deventer, S.J. and Tytgat, G.N. (1994) Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol, 29, 425-429.
55. Keates, S., Keates, A.C., Warny, M., Peek, R.M., Jr., Murray, P.G. and Kelly, C.P. (1999) Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cag- Helicobacter pylori. J Immunol, 163, 5552-5559.
56. Naumann, M., Wessler, S., Bartsch, C., Wieland, B., Covacci, A., Haas, R. and Meyer, T.F. (1999) Activation of activator protein 1 and stress response kinases in epithelial cells colonized by Helicobacter pylori encoding the cag pathogenicity island. J Biol Chem, 274, 31655-31662.
57. Aihara, M., Tsuchimoto, D., Takizawa, H., Azuma, A., Wakebe, H., Ohmoto, Y., Imagawa, K., Kikuchi, M., Mukaida, N. and Matsushima, K. (1997) Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45. Infect Immun, 65, 3218-3224.
58. Konturek, P.C., Kania, J., Kukharsky, V., Ocker, S., Hahn, E.G. and Konturek, S.J. (2003) Influence of gastrin on the expression of cyclooxygenase-2, hepatocyte growth factor and apoptosis-related proteins in gastric epithelial cells. J Physiol Pharmacol, 54, 17-32.
59. Macarthur, M., Hold, G.L. and El-Omar, E.M. (2004) Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol, 286, G515-520.
60. Saukkonen, K., Rintahaka, J., Sivula, A., Buskens, C.J., Van Rees, B.P., Rio, M.C., Haglund, C., Van Lanschot, J.J., Offerhaus, G.J. and Ristimaki, A. (2003) Cyclooxygenase-2 and gastric carcinogenesis. Apmis, 111, 915-925.
61. Takahashi, N., Okumura, T., Motomura, W., Fujimoto, Y., Kawabata, I. and Kohgo, Y. (1999) Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells. FEBS Lett, 455, 135-139.
62. Churin, Y., Al-Ghoul, L., Kepp, O., Meyer, T.F., Birchmeier, W. and Naumann, M. (2003) Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J Cell Biol, 161, 249-255.
63. Keates, S., Sougioultzis, S., Keates, A.C., Zhao, D., Peek, R.M., Jr., Shaw, L.M. and Kelly, C.P. (2001) cag+ Helicobacter pylori induce transactivation of the epidermal growth factor receptor in AGS gastric epithelial cells. J Biol Chem, 276, 48127-48134.
64. Wallasch, C., Crabtree, J.E., Bevec, D., Robinson, P.A., Wagner, H. and Ullrich, A. (2002) Helicobacter pylori-stimulated EGF receptor transactivation requires metalloprotease cleavage of HB-EGF. Biochem Biophys Res Commun, 295, 695-701.
65. Backert, S., Gressmann, H., Kwok, T., Zimny-Arndt, U., Konig, W., Jungblut, P.R. and Meyer, T.F. (2005) Gene expression and protein profiling of AGS gastric epithelial cells upon infection with Helicobacter pylori. Proteomics, 5, 3902-3918.
66. Chan, C.H., Ko, C.C., Chang, J.G., Chen, S.F., Wu, M.S., Lin, J.T. and Chow, L.P. (2006) Subcellular and functional proteomic analysis of the cellular responses induced by Helicobacter pylori. Mol Cell Proteomics, 5, 702-713.
67. Frohlich, K.U., Fries, H.W., Rudiger, M., Erdmann, R., Botstein, D. and Mecke, D. (1991) Yeast cell cycle protein CDC48p shows full-length homology to the mammalian protein VCP and is a member of a protein family involved in secretion, peroxisome formation, and gene expression. J Cell Biol, 114, 443-453.
68. Koller, K.J. and Brownstein, M.J. (1987) Use of a cDNA clone to identify a supposed precursor protein containing valosin. Nature, 325, 542-545.
69. Pamnani, V., Tamura, T., Lupas, A., Peters, J., Cejka, Z., Ashraf, W. and Baumeister, W. (1997) Cloning, sequencing and expression of VAT, a CDC48/p97 ATPase homologue from the archaeon Thermoplasma acidophilum. FEBS Lett, 404, 263-268.
70. Peters, J.M., Walsh, M.J. and Franke, W.W. (1990) An abundant and ubiquitous homo-oligomeric ring-shaped ATPase particle related to the putative vesicle fusion proteins Sec18p and NSF. Embo J, 9, 1757-1767.
71. Neuwald, A.F., Aravind, L., Spouge, J.L. and Koonin, E.V. (1999) AAA+: A class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res, 9, 27-43.
72. Woodman, P.G. (2003) p97, a protein coping with multiple identities. J Cell Sci, 116, 4283-4290.
73. Hershko, A. and Ciechanover, A. (1998) The ubiquitin system. Annu Rev Biochem, 67, 425-479.
74. Moir, D., Stewart, S.E., Osmond, B.C. and Botstein, D. (1982) Cold-sensitive cell-division-cycle mutants of yeast: isolation, properties, and pseudoreversion studies. Genetics, 100, 547-563.
75. Dai, R.M. and Li, C.C. (2001) Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation. Nat Cell Biol, 3, 740-744.
76. Dai, R.M., Chen, E., Longo, D.L., Gorbea, C.M. and Li, C.C. (1998) Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha. J Biol Chem, 273, 3562-3573.
77. Ghislain, M., Dohmen, R.J., Levy, F. and Varshavsky, A. (1996) Cdc48p interacts with Ufd3p, a WD repeat protein required for ubiquitin-mediated proteolysis in Saccharomyces cerevisiae. Embo J, 15, 4884-4899.
78. Kaneko, C., Hatakeyama, S., Matsumoto, M., Yada, M., Nakayama, K. and Nakayama, K.I. (2003) Characterization of the mouse gene for the U-box-type ubiquitin ligase UFD2a. Biochem Biophys Res Commun, 300, 297-304.
79. Koegl, M., Hoppe, T., Schlenker, S., Ulrich, H.D., Mayer, T.U. and Jentsch, S. (1999) A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell, 96, 635-644.
80. Meyer, H.H., Shorter, J.G., Seemann, J., Pappin, D. and Warren, G. (2000) A complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways. Embo J, 19, 2181-2192.
81. Rothman, J.E. and Warren, G. (1994) Implications of the SNARE hypothesis for intracellular membrane topology and dynamics. Curr Biol, 4, 220-233.
82. Latterich, M., Frohlich, K.U. and Schekman, R. (1995) Membrane fusion and the cell cycle: Cdc48p participates in the fusion of ER membranes. Cell, 82, 885-893.
83. Zhang, L., Ashendel, C.L., Becker, G.W. and Morre, D.J. (1994) Isolation and characterization of the principal ATPase associated with transitional endoplasmic reticulum of rat liver. J Cell Biol, 127, 1871-1883.
84. Acharya, U., Jacobs, R., Peters, J.M., Watson, N., Farquhar, M.G. and Malhotra, V. (1995) The formation of Golgi stacks from vesiculated Golgi membranes requires two distinct fusion events. Cell, 82, 895-904.
85. Rabouille, C., Levine, T.P., Peters, J.M. and Warren, G. (1995) An NSF-like ATPase, p97, and NSF mediate cisternal regrowth from mitotic Golgi fragments. Cell, 82, 905-914.
86. Kondo, H., Rabouille, C., Newman, R., Levine, T.P., Pappin, D., Freemont, P. and Warren, G. (1997) p47 is a cofactor for p97-mediated membrane fusion. Nature, 388, 75-78.
87. Rabouille, C., Kondo, H., Newman, R., Hui, N., Freemont, P. and Warren, G. (1998) Syntaxin 5 is a common component of the NSF- and p97-mediated reassembly pathways of Golgi cisternae from mitotic Golgi fragments in vitro. Cell, 92, 603-610.
88. Hetzer, M., Meyer, H.H., Walther, T.C., Bilbao-Cortes, D., Warren, G. and Mattaj, I.W. (2001) Distinct AAA-ATPase p97 complexes function in discrete steps of nuclear assembly. Nat Cell Biol, 3, 1086-1091.
89. Kozutsumi, Y., Segal, M., Normington, K., Gething, M.J. and Sambrook, J. (1988) The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature, 332, 462-464.
90. Bays, N.W., Wilhovsky, S.K., Goradia, A., Hodgkiss-Harlow, K. and Hampton, R.Y. (2001) HRD4/NPL4 is required for the proteasomal processing of ubiquitinated ER proteins. Mol Biol Cell, 12, 4114-4128.
91. Hitchcock, A.L., Krebber, H., Frietze, S., Lin, A., Latterich, M. and Silver, P.A. (2001) The conserved npl4 protein complex mediates proteasome-dependent membrane-bound transcription factor activation. Mol Biol Cell, 12, 3226-3241.
92. Jarosch, E., Taxis, C., Volkwein, C., Bordallo, J., Finley, D., Wolf, D.H. and Sommer, T. (2002) Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48. Nat Cell Biol, 4, 134-139.
93. Rabinovich, E., Kerem, A., Frohlich, K.U., Diamant, N. and Bar-Nun, S. (2002) AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol Cell Biol, 22, 626-634.
94. Rape, M., Hoppe, T., Gorr, I., Kalocay, M., Richly, H. and Jentsch, S. (2001) Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone. Cell, 107, 667-677.
95. Ye, Y., Meyer, H.H. and Rapoport, T.A. (2001) The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature, 414, 652-656.
96. Meusser, B., Hirsch, C., Jarosch, E. and Sommer, T. (2005) ERAD: the long road to destruction. Nat Cell Biol, 7, 766-772.
97. Asai, T., Tomita, Y., Nakatsuka, S., Hoshida, Y., Myoui, A., Yoshikawa, H. and Aozasa, K. (2002) VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line. Jpn J Cancer Res, 93, 296-304.
98. Ghosh, S., May, M.J. and Kopp, E.B. (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol, 16, 225-260.
99. Karin, M. and Ben-Neriah, Y. (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol, 18, 621-663.
100. Santoro, M.G., Rossi, A. and Amici, C. (2003) NF-kappaB and virus infection: who controls whom. Embo J, 22, 2552-2560.
101. Silverman, N. and Maniatis, T. (2001) NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev, 15, 2321-2342.
102. Lin, L. and Ghosh, S. (1996) A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit. Mol Cell Biol, 16, 2248-2254.
103. Egerton, M., Ashe, O.R., Chen, D., Druker, B.J., Burgess, W.H. and Samelson, L.E. (1992) VCP, the mammalian homolog of cdc48, is tyrosine phosphorylated in response to T cell antigen receptor activation. Embo J, 11, 3533-3540.
104. Yamada, T., Okuhara, K., Iwamatsu, A., Seo, H., Ohta, K., Shibata, T. and Murofushi, H. (2000) p97 ATPase, an ATPase involved in membrane fusion, interacts with DNA unwinding factor (DUF) that functions in DNA replication. FEBS Lett, 466, 287-291.
105. Zhang, H., Wang, Q., Kajino, K. and Greene, M.I. (2000) VCP, a weak ATPase involved in multiple cellular events, interacts physically with BRCA1 in the nucleus of living cells. DNA Cell Biol, 19, 253-263.
106. Madeo, F., Schlauer, J., Zischka, H., Mecke, D. and Frohlich, K.U. (1998) Tyrosine phosphorylation regulates cell cycle-dependent nuclear localization of Cdc48p. Mol Biol Cell, 9, 131-141.
107. Nakayama, K.I. and Nakayama, K. (2006) Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer, 6, 369-381.
108. Jesenberger, V. and Jentsch, S. (2002) Deadly encounter: ubiquitin meets apoptosis. Nat Rev Mol Cell Biol, 3, 112-121.
109. Varshavsky, A. (2003) The N-end rule and regulation of apoptosis. Nat Cell Biol, 5, 373-376.
110. Yang, Y. and Yu, X. (2003) Regulation of apoptosis: the ubiquitous way. Faseb J, 17, 790-799.
111. Shirogane, T., Fukada, T., Muller, J.M., Shima, D.T., Hibi, M. and Hirano, T. (1999) Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. Immunity, 11, 709-719.
112. Imamura, S., Ojima, N. and Yamashita, M. (2003) Cold-inducible expression of the cell division cycle gene CDC48 and its promotion of cell proliferation during cold acclimation in zebrafish cells. FEBS Lett, 549, 14-20.
113. Wu, D., Chen, P.J., Chen, S., Hu, Y., Nunez, G. and Ellis, R.E. (1999) C. elegans MAC-1, an essential member of the AAA family of ATPases, can bind CED-4 and prevent cell death. Development, 126, 2021-2031.
114. Wang, Q., Song, C. and Li, C.C. (2004) Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions. J Struct Biol, 146, 44-57.
115. Tsujimoto, Y., Tomita, Y., Hoshida, Y., Kono, T., Oka, T., Yamamoto, S., Nonomura, N., Okuyama, A. and Aozasa, K. (2004) Elevated expression of valosin-containing protein (p97) is associated with poor prognosis of prostate cancer. Clin Cancer Res, 10, 3007-3012.
116. Yamamoto, S., Tomita, Y., Hoshida, Y., Iizuka, N., Kidogami, S., Miyata, H., Takiguchi, S., Fujiwara, Y., Yasuda, T., Yano, M. et al. (2004) Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma. Clin Cancer Res, 10, 5558-5565.
117. Yamamoto, S., Tomita, Y., Hoshida, Y., Iizuka, N., Monden, M., Yamamoto, S., Iuchi, K. and Aozasa, K. (2004) Expression level of valosin-containing protein (p97) is correlated with progression and prognosis of non-small-cell lung carcinoma. Ann Surg Oncol, 11, 697-704.
118. Yamamoto, S., Tomita, Y., Hoshida, Y., Nagano, H., Dono, K., Umeshita, K., Sakon, M., Ishikawa, O., Ohigashi, H., Nakamori, S. et al. (2004) Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma. Ann Surg Oncol, 11, 165-172.
119. Yamamoto, S., Tomita, Y., Hoshida, Y., Sakon, M., Kameyama, M., Imaoka, S., Sekimoto, M., Nakamori, S., Monden, M. and Aozasa, K. (2004) Expression of valosin-containing protein in colorectal carcinomas as a predictor for disease recurrence and prognosis. Clin Cancer Res, 10, 651-657.
120. Yamamoto, S., Tomita, Y., Hoshida, Y., Takiguchi, S., Fujiwara, Y., Yasuda, T., Yano, M., Nakamori, S., Sakon, M., Monden, M. et al. (2003) Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma. J Clin Oncol, 21, 2537-2544.
121. Yamamoto, S., Tomita, Y., Hoshida, Y., Toyosawa, S., Inohara, H., Kishino, M., Kogo, M., Nakazawa, M., Murakami, S., Iizuka, N. et al. (2004) Expression level of valosin-containing protein (VCP) as a prognostic marker for gingival squamous cell carcinoma. Ann Oncol, 15, 1432-1438.
122. Yamamoto, S., Tomita, Y., Nakamori, S., Hoshida, Y., Nagano, H., Dono, K., Umeshita, K., Sakon, M., Monden, M. and Aozasa, K. (2003) Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence. J Clin Oncol, 21, 447-452.
123. Yamamoto, S., Tomita, Y., Uruno, T., Hoshida, Y., Qiu, Y., Iizuka, N., Nakamichi, I., Miyauchi, A. and Aozasa, K. (2005) Increased expression of valosin-containing protein (p97) is correlated with disease recurrence in follicular thyroid cancer. Ann Surg Oncol, 12, 925-934.
124. Vandermoere, F., El Yazidi-Belkoura, I., Slomianny, C., Demont, Y., Bidaux, G., Adriaenssens, E., Lemoine, J. and Hondermarck, H. (2006) The valosin-containing protein (VCP) is a target of Akt signaling required for cell survival. J Biol Chem, 281, 14307-14313.
125. Wojcik, C., Yano, M. and DeMartino, G.N. (2004) RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysis. J Cell Sci, 117, 281-292.
126. Moritz, R.L., Eddes, J.S., Reid, G.E. and Simpson, R.J. (1996) S-pyridylethylation of intact polyacrylamide gels and in situ digestion of electrophoretically separated proteins: a rapid mass spectrometric method for identifying cysteine-containing peptides. Electrophoresis, 17, 907-917.
127. Su, B., Ceponis, P.J. and Sherman, P.M. (2003) Cytoskeletal rearrangements in gastric epithelial cells in response to Helicobacter pylori infection. J Med Microbiol, 52, 861-867.
128. Selbach, M., Moese, S., Meyer, T.F. and Backert, S. (2002) Functional analysis of the Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent and VirD4-CagA-independent mechanisms. Infect Immun, 70, 665-671.
129. Bourzac, K.M. and Guillemin, K. (2005) Helicobacter pylori-host cell interactions mediated by type IV secretion. Cell Microbiol, 7, 911-919.
130. Pommier, Y., Sordet, O., Antony, S., Hayward, R.L. and Kohn, K.W. (2004) Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene, 23, 2934-2949.
131. Shibahara, T., Onishi, T., Franco, O.E., Arima, K. and Sugimura, Y. (2005) Down-regulation of Skp2 is correlated with p27-associated cell cycle arrest induced by phenylacetate in human prostate cancer cells. Anticancer Res, 25, 1881-1888.
132. van Duijn, P.W. and Trapman, J. (2006) PI3K/Akt signaling regulates p27(kip1) expression via Skp2 in PC3 and DU145 prostate cancer cells, but is not a major factor in p27(kip1) regulation in LNCaP and PC346 cells. Prostate, 66, 749-760.
133. Mayo, L.D. and Donner, D.B. (2002) The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. Trends Biochem Sci, 27, 462-467.
134. Mayo, L.D. and Donner, D.B. (2001) A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci U S A, 98, 11598-11603.
135. Zhou, B.P., Liao, Y., Xia, W., Zou, Y., Spohn, B. and Hung, M.C. (2001) HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol, 3, 973-982.
136. Welcker, M., Orian, A., Jin, J., Grim, J.E., Harper, J.W., Eisenman, R.N. and Clurman, B.E. (2004) The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci U S A, 101, 9085-9090.
137. Gort, E.H., Groot, A.J., Derks van de Ven, T.L., van der Groep, P., Verlaan, I., van Laar, T., van Diest, P.J., van der Wall, E. and Shvarts, A. (2006) Hypoxia-inducible factor-1alpha expression requires PI 3-kinase activity and correlates with Akt1 phosphorylation in invasive breast carcinomas. Oncogene.
138. Zhong, H., Chiles, K., Feldser, D., Laughner, E., Hanrahan, C., Georgescu, M.M., Simons, J.W. and Semenza, G.L. (2000) Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res, 60, 1541-1545.
139. Yang, G.F., Deng, C.S., Xiong, Y.Y., Gong, L.L., Wang, B.C. and Luo, J. (2004) Expression of nuclear factor-kappa B and target genes in gastric precancerous lesions and adenocarcinoma: association with Helicobactor pylori cagA (+) infection. World J Gastroenterol, 10, 491-496.
140. Lindroos, P.M., Rice, A.B., Wang, Y.Z. and Bonner, J.C. (1998) Role of nuclear factor-kappa B and mitogen-activated protein kinase signaling pathways in IL-1 beta-mediated induction of alpha-PDGF receptor expression in rat pulmonary myofibroblasts. J Immunol, 161, 3464-3468.
141. George, D. (2001) Platelet-derived growth factor receptors: a therapeutic target in solid tumors. Semin Oncol, 28, 27-33.
142. Matei, D., Emerson, R.E., Lai, Y.C., Baldridge, L.A., Rao, J., Yiannoutsos, C. and Donner, D.D. (2006) Autocrine activation of PDGFRalpha promotes the progression of ovarian cancer. Oncogene, 25, 2060-2069.
143. Smith, J.S., Wang, X.Y., Qian, J., Hosek, S.M., Scheithauer, B.W., Jenkins, R.B. and James, C.D. (2000) Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features. J Neuropathol Exp Neurol, 59, 495-503.
144. Jones, A.V. and Cross, N.C. (2004) Oncogenic derivatives of platelet-derived growth factor receptors. Cell Mol Life Sci, 61, 2912-2923.
145. Boissel, N., Rea, D., Tieng, V., Dulphy, N., Brun, M., Cayuela, J.M., Rousselot, P., Tamouza, R., Le Bouteiller, P., Mahon, F.X. et al. (2006) BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia. J Immunol, 176, 5108-5116.
146. Holdenrieder, S., Stieber, P., Peterfi, A., Nagel, D., Steinle, A. and Salih, H.R. (2006) Soluble MICA in malignant diseases. Int J Cancer, 118, 684-687.
147. Jinushi, M., Takehara, T., Tatsumi, T., Hiramatsu, N., Sakamori, R., Yamaguchi, S. and Hayashi, N. (2005) Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. J Hepatol, 43, 1013-1020.
148. Mitsuhashi, T., Li, Y.M., Fishbane, S. and Vlassara, H. (1997) Depletion of reactive advanced glycation endproducts from diabetic uremic sera using a lysozyme-linked matrix. J Clin Invest, 100, 847-854.
149. Zheng, F., Cai, W., Mitsuhashi, T. and Vlassara, H. (2001) Lysozyme enhances renal excretion of advanced glycation endproducts in vivo and suppresses adverse age-mediated cellular effects in vitro: a potential AGE sequestration therapy for diabetic nephropathy? Mol Med, 7, 737-747.
150. Liu, H., Zheng, F., Cao, Q., Ren, B., Zhu, L., Striker, G. and Vlassara, H. (2006) Amelioration of oxidant stress by the defensin lysozyme. Am J Physiol Endocrinol Metab, 290, E824-832.
151. Coles, B., Nowell, S.A., MacLeod, S.L., Sweeney, C., Lang, N.P. and Kadlubar, F.F. (2001) The role of human glutathione S-transferases (hGSTs) in the detoxification of the food-derived carcinogen metabolite
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/32217-
dc.description.abstract摘要
胃癌是世界上最常見癌症中的第四名,也是所有癌症死亡率的第二名,全球每年至少有七十萬人死於此疾病。胃癌發生的原因很多,其中一個非常重要的因子乃幽門螺旋桿菌 (Helicobacter pylori, H. pylori)。近年來許多科學家致力於研究幽門螺旋桿菌導致胃癌的機制,使用的研究方法包括動物實驗、mRNA 微陣列技術 (mRNA microarray)、蛋白質體學技術 (proteomics approach) 等,希望能找出幽門螺旋桿菌感染引起的差異性表現基因或蛋白質,以進一步探討胃癌發生的分子機制。本實驗室利用蛋白質體學技術,比較感染幽門螺旋桿菌及未感染的 AGS 胃腺癌細胞,發現幽門螺旋桿菌感染後表現量會上升的蛋白質,有許多是可能導致癌症的因子,其中一個重要的蛋白質為 valosin-containing protein (VCP)。近年來發現 VCP 在許多不同的癌症都有大量表現的情形,且其在病人組織中的含量可作為癌症預後狀況的指標。然而 VCP 與癌症發展之間的關係目前尚未完全研究清楚。本論文的實驗目的是希望利用蛋白質體學技術,研究 AGS 胃腺癌細胞大量表現 VCP 後,會看到哪些差異性表現的蛋白質。
利用二維螢光差異凝膠電泳 (2-D DIGE) 分析,發現 VCP 大量表現後會增加表現的宿主蛋白質有 16 個,會減少表現的有 15 個,然後利用膠體內水解及串聯質譜儀鑑定這些蛋白質的身份;再配合本實驗室詹佳欣學姊利用 mRNA microarray 找到 VCP 大量表現造成的差異性表現基因;以及搜尋現有文獻;並根據西方墨點法,得到下列五點實驗結果:(1) 許多mRNA microarray 分析中表現量上升的基因為 NF-κB 的下游產物,且 p-IκBα 含量會下降 (西方墨點法);(2) 利用西方墨點法發現抑制細胞週期的 p21、p27 及促進細胞凋亡的 p53 蛋白質量會下降,而促進細胞週期進行的 cyclin D1 會上升;(3) GADD34、GADD45基因表現量下降 (mRNA microarray),以及 eIF4E (2-D DIGE)、c-Myc (西方墨點法) 蛋白質量上升;(4) keratin 19、cathepsin D (2-D DIGE)、Hif-1α (西方墨點法) 蛋白質含量上升;(5) 幽門螺旋桿菌促使 p-IκBα 含量下降以及 Hif-1α 含量上升的情形,在加入 VCP siRNA 後會消失。以上證據顯示 VCP 大量表現後,一方面促使細胞存活、生長與增殖,另一方面也會抑制細胞凋亡。由於文獻報導 VCP 對於 Akt 訊息傳遞是必要的,因此推測上述看到的現象乃因大量表現的 VCP 促進了 Akt 的下游訊息。
本篇論文結合 mRNA 微陣列及蛋白質體學技術,找到許多會受 VCP 調控之宿主細胞因子,並且由這些實驗結果,暗示了 Akt/VCP 的訊息傳導可能在幽門螺旋桿菌所誘導的胃癌機制中扮演一個重要的角色。未來經過更進一步實驗確認後,將可針對可能的 Akt 訊息傳導路徑來找尋抑制幽門螺旋桿菌導致之胃癌的方法。
zh_TW
dc.description.abstractAbstract
Gastric cancer is the fourth most common cancer and the second most common cause of cancer-related death in the world — killing more than 700,000 people every year. There are many factors that lead to gastric cancer, one of which is infection by Helicobacter pylori (H .pylori). For the past few years, by utilizing proteomics approaches, mRNA microarray analyses, and animal model experiments, many scientists have devoted their efforts in studying the mechanisms of gastric cancer progression caused by H. pylori. By using proteomics approaches, our laboratory found that the protein expression level of many cancer-related factors were elevated in AGS cells after H. pylori infection, and one important factor was valosin-containing protein (VCP). It is found recently that VCP overexpresses in almost every kind of cancer, and the level of VCP in cancerous tissues is a prognosis marker for cancer diseases. The specific aim of this thesis is to investigate the differential-expressed proteins in AGS cells after overexpressing VCP by proteomics approaches.
Sixteen proteins were up-regulated and fifteen proteins were down- regulated after VCP overexpression in 2-D DIGE analyses. According to LC-MS/MS identification, mRNA microarray analyses, literature search, and Western blot (WB) confirmation, we got the following five results: (1) many genes with increased expression level in mRNA microarray analyses were downstream products of the transcription factor NF-κB, and the protein level of p-IκBα was decreased (WB); (2) the protein level of cell cycle inhibitors, p21 and p27, and the proapoptotic factor p53 were decreased; on the other hand, the cell cycle promoting factor cyclin D1 was increased (WB); (3) the gene expression level of GADD34 and GADD45 (mRNA microarray) were decreased, and the protein level of eIF4E (2-D DIGE) and c-Myc (WB) were increased; (4) keratin 19, cathepsin D (2-D DIGE), and Hif-1α (WB) were up-regulated in protein level; (5) the phenomena of H. pylori-induced p-IκBα down-regulation and Hif-1α up-regulation were diminished after adding VCP siRNA. The aforesaid evidences indicated that VCP not only promoted AGS cell survival, growth and proliferation, but also inhibited apoptosis. VCP was documented to play an essential role in Akt downstream signaling, so we proposed the aforementioned findings were caused by the facilitation of Akt signaling in VCP-overexpressed cells.
Combining mRNA microarray analyses and proteomics approaches, we have found many host factors regulated by VCP. According to the results, we proposed that Akt/VCP signaling might play an important role in H. pylori-caused gastric cancer.
en
dc.description.provenanceMade available in DSpace on 2021-06-13T03:37:15Z (GMT). No. of bitstreams: 1
ntu-95-R93442001-1.pdf: 2874822 bytes, checksum: f3fe3c5a70675b7458f232a30a45870c (MD5)
Previous issue date: 2006
en
dc.description.tableofcontents摘要••••••••••••••••••••••••••••••••••••••••••••••i
Abstract••••••••••••••••••••••••••••••••••••••••••ii
縮寫表 (abbreviations)••••••••••••••••••••••••••••••1
第一章 導論•••••••••••••••••••••••••••••••••••••••3
第一節 胃癌簡介••••••••••••••••••••••••••••••••••3
第二節 幽門螺旋桿菌的流行病學及胃癌•••••••••••••••••6
第三節 Valosin-containing protein (VCP) 扮演的角色•••••9
第四節 本篇論文的實驗目的•••••••••••••••••••••••••15
第二章 實驗材料••••••••••••••••••••••••••••••••••••16
第三章 實驗方法••••••••••••••••••••••••••••••••••••19
第一節 幽門螺旋桿菌與胃腺癌細胞的培養•••••••••••••••19
第二節 幽門螺旋桿菌感染胃腺癌細胞•••••••••••••••••••20
第三節 蛋白質分析法•••••••••••••••••••••••••••••••22
第四節 胃腺癌細胞的二維電泳分析••••••••••••••••••••26
第五節 VCP 所影響之差異性表現蛋白質的鑑定••••••••••••30
第四章 實驗結果••••••••••••••••••••••••••••••••••••32
第一節 幽門螺旋桿菌感染促使宿主細胞大量表現 VCP 蛋白質32
第二節 VCP 蛋白質大量表現影響之宿主細胞下游因子••••••33
第三節 VCP 蛋白質的大量表現與胃癌的關係•••••••••••••••35
第五章 實驗討論••••••••••••••••••••••••••••••••••••37
第一節 實驗方法討論——2-D DIGE 分析法的優點與限制•••••37
第二節 訊息傳導模型的意義•••••••••••••••••••••••••37
第三節 VCP 大量表現所影響的其他差異性表現蛋白質••••••43
第四節 總結與未來展望•••••••••••••••••••••••••••••44
第六章 參考文獻••••••••••••••••••••••••••••••••••••46
第七章 圖表與說明••••••••••••••••••••••••••••••••••66
附錄••••••••••••••••••••••••••••••••••••••••••••••77
dc.language.isozh-TW
dc.subject串聯質譜儀zh_TW
dc.subject幽門螺旋桿菌zh_TW
dc.subject胃癌zh_TW
dc.subject蛋白質體學zh_TW
dc.subjectLC-MS/MSen
dc.subjectH. pylorien
dc.subjectgastric canceren
dc.subjectVCPen
dc.subjectproteomicsen
dc.subject2-D DIGEen
dc.title利用蛋白質體學鑑定受 Valosin-containing protein 調控之宿主細胞因子zh_TW
dc.titleIdentification of the Host Factors Regulated by Valosin-Containing Protein by Proteomics Approachesen
dc.typeThesis
dc.date.schoolyear94-2
dc.description.degree碩士
dc.contributor.oralexamcommittee余兆松(Jau-Song Yu),張嘉哲(Chia-Che Chang)
dc.subject.keyword幽門螺旋桿菌,胃癌,蛋白質體學,串聯質譜儀,zh_TW
dc.subject.keywordH. pylori,gastric cancer,VCP,proteomics,2-D DIGE,LC-MS/MS,en
dc.relation.page83
dc.rights.note有償授權
dc.date.accepted2006-07-27
dc.contributor.author-college醫學院zh_TW
dc.contributor.author-dept生物化學暨分子生物學研究所zh_TW
顯示於系所單位:生物化學暨分子生物學科研究所

文件中的檔案:
檔案 大小格式 
ntu-95-1.pdf
  未授權公開取用
2.81 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved